(UroToday.com) At the 2026 European Society for Medical Oncology (ESMO) Annual Congress, Dr. Laurence Albiges and colleagues presented the study design of LUTEON, an ongoing, randomized phase III ...
The 2026 ESMO annual meeting featured a prostate cancer session and a presentation by Dr. Mehdi Bsilat discussing the impact ...
(UroToday.com) The 2026 European Society of Medical Oncology (ESMO) Annual Congress held the session: Genitourinary tumour, ...
Most CTC-evaluable patients in TALAPRO-2 had relatively low CTC burden at baseline, with 81.5% having <5 CTCs/7.5 mL and 65.3 ...
Radical cystectomy remains a major operation even at experienced centers and with robotic surgical techniques. Data from the ...
The 2026 ESMO annual meeting featured a rapid oral session and a discussant presentation by Dr. Alison Reid discussing three ...
This analysis included 58 patients treated with gemcitabine intravesical system monotherapy in the SunRISe-1 cohort who had available utDNA molecular residual disease results at baseline or week 12.
A total of 25 patients who received ≥2 cycles of toripalimab combined with TIP chemotherapy were enrolled. The objective response rate was 84.0%, with 2 patients achieving complete response and 19 ...
Low Frequency of Sexual Intercourse, Discrepancy Between Erectile Function Measures, and Sexual Satisfaction Among Japanese Men Aged 45-64 Years: A Nationwide Cross-Sectional Study. Elevated Prostate ...
San Francisco, California (UroToday.com) Based on preclinical data from mouse models looking at radiation therapy combined with dual anti-PDL1 and anti-CTLA4 immune checkpoint blockade in cancer that ...
Pain and Health-Related Quality-of-Life Outcomes with Darolutamide in Metastatic Hormone-Sensitive Prostate Cancer (ARANOTE): Secondary and Exploratory Analyses of a Multicentre, Randomised, ...
Post-Treatment Response and Safety of Stem Cell-Based Urethral Injection Therapy for Female Stress Urinary Incontinence: A Systematic Review and Meta-Analysis. Female stress urinary incontinence ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results